Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,417 | 198 | 93.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $192.00 | 3 | 5.2% |
| Education | $61.85 | 16 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $642.11 | 48 | $0 (2021) |
| PFIZER INC. | $629.99 | 43 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $436.32 | 14 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $342.14 | 10 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $296.64 | 20 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $202.22 | 11 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $194.02 | 24 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $164.75 | 3 | $0 (2020) |
| Allergan, Inc. | $151.94 | 8 | $0 (2020) |
| Novo Nordisk Inc | $143.94 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.00 | 1 | Becton, Dickinson and Company ($25.00) |
| 2021 | $308.90 | 14 | PFIZER INC. ($130.12) |
| 2020 | $487.59 | 24 | Teva Pharmaceuticals USA, Inc. ($124.75) |
| 2019 | $594.32 | 24 | Novartis Pharmaceuticals Corporation ($146.94) |
| 2018 | $317.58 | 16 | Allergan Inc. ($93.96) |
| 2017 | $1,937 | 138 | PFIZER INC. ($337.66) |
All Payment Transactions
217 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/19/2024 | Becton, Dickinson and Company | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $25.00 | General |
| 12/09/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $72.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/22/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/18/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/28/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: RESPIRATORY | ||||||
| 04/27/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/11/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/01/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/29/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/21/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/19/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/04/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Respiratory | ||||||
| 12/09/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/08/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/22/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Diabetes | ||||||
| 09/23/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/16/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: RESPIRATORY | ||||||
| 08/17/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/15/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 424 | 474 | $111,652 | $31,472 |
| 2020 | 9 | 797 | 1,206 | $262,923 | $77,139 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 222 | 255 | $63,750 | $20,923 | 32.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 139 | 155 | $37,510 | $7,327 | 19.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 41 | $7,093 | $2,160 | 30.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 12 | $1,968 | $618.20 | 31.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 11 | 11 | $1,331 | $443.50 | 33.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 406 | 754 | $184,620 | $49,957 | 27.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 184 | 224 | $48,895 | $17,611 | 36.0% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 20 | 22 | $11,405 | $4,290 | 37.6% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 39 | 45 | $5,445 | $1,929 | 35.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 38 | $6,340 | $1,267 | 20.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 17 | $2,018 | $846.66 | 42.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 72 | 78 | $2,652 | $611.49 | 23.1% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 11 | 12 | $1,116 | $344.93 | 30.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 16 | 16 | $432.00 | $282.32 | 65.4% |
About Dr. Sheldon Lyons, MD
Dr. Sheldon Lyons, MD is a Internal Medicine healthcare provider based in Springfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811962962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheldon Lyons, MD has received a total of $3,671 in payments from pharmaceutical and medical device companies, with $25.00 received in 2024. These payments were reported across 217 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,417).
As a Medicare-enrolled provider, Lyons has provided services to 1,221 Medicare beneficiaries, totaling 1,680 services with total Medicare billing of $108,611. Data is available for 2 years (2020–2021), covering 14 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Springfield, MA
- Active Since 02/22/2006
- Last Updated 04/01/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811962962
Products in Payments
- ELIQUIS (Drug) $303.11
- ENTRESTO (Drug) $274.14
- CHANTIX (Drug) $273.72
- TRELEGY ELLIPTA (Drug) $227.81
- ANORO (Drug) $175.27
- PRALUENT (Drug) $168.02
- FARXIGA (Drug) $159.12
- SOLIQUA (Drug) $143.29
- BREO (Drug) $136.98
- AJOVY (Biological) $124.75
- VRAYLAR (Drug) $109.11
- TRULICITY (Drug) $103.85
- INVOKANA (Drug) $101.41
- XARELTO (Drug) $100.81
- BEVESPI AEROSPHERE (Drug) $97.76
- JARDIANCE (Drug) $80.15
- TOUJEO (Biological) $72.00
- Victoza (Drug) $64.16
- MYRBETRIQ (Drug) $63.51
- Prolia (Biological) $63.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Springfield
Dr. Steven Gradney, M.d, M.D
Internal Medicine — Payments: $568,658
Dr. James Bonucchi, Do, DO
Internal Medicine — Payments: $304,681
John Flack, Md, Mph, MD, MPH
Internal Medicine — Payments: $125,897
Dr. Sudeshna Banerjee, Md, MD
Internal Medicine — Payments: $62,767
Dr. Paul Madaj, M.d, M.D
Internal Medicine — Payments: $58,030
Dr. Indrajeet Mahata, M.d, M.D
Internal Medicine — Payments: $47,372